Everyday Health on MSN
Experimental Obesity Drug Could Soon Compete With Wegovy and Zepbound
Drugmaker Eli Lilly said it would soon start late-stage trials for eloralintide, a drug mimicking the pancreatic hormone ...
Q3 2025 Earnings Call November 10, 2025 5:00 PM ESTCompany ParticipantsMark Goldston - Executive ChairmanCarl Daikeler ...
Karilyn Burdick-Greenwood was the first Cal State Fullerton women’s gymnast to compete in an international meet in Romania, ...
The maintenance segment continued its strong growth in Q3 2025 with third-party revenues up 12.9%, driven by a strong recovery in engine activities. Total revenues rose 10.2%. The operating result ...
Net revenue grew 57% year-over-year to $109.5 million GAAP net loss of $102.1 million, impacted by one-time loss on ...
SE25-053 Highlights: 1.1 meters grading 27.0% Zn, 60.1 g/t Ag, 1.5 g/t Au, 0.7% Pb, 0.4% Cu, 0.03% Sb (or 766.4 g/t AgEq) and ...
Nevada's record quarterly results benefited from a combination of higher gold prices, strong operations, new acquisitions and the sale of Cobre Panama copper concentrate stockpiles. Our acquisition of ...
Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), the nation’s largest provider of end-of-life care, and Roto-Rooter, the nation’s largest commercial and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback